Flexion Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Flexion Price Target Raised To $25 From $19 At Benchmark
Article By: The Fly
Friday, December 27, 2019 11:16 AM EST
Benchmark analyst Bruce Jackson raised his price target for Flexion Therapeutics to $25 from $19 after the company received FDA approval to update the product label for Zilretta for the treatment of osteoarthritis knee pain.
In this article: FLXN
Read
E Wither Flexion?
Article By: Ketan Desai
Sunday, November 24, 2019 1:13 PM EST
A new study highlights that there are likely fewer candidates for Flexion's star osteoarthritis treatment and this could affect the stock price of Flexion considerably.
In this article: FLXN
Read
3 Biotech And Pharma Stocks With Key FDA Catalysts This October
Article By: Arpita Dutt
Monday, October 2, 2017 10:16 AM EST
The FDA, which approved 22 novel drugs last year, has given its approval to 34 drugs so far in 2017 including three in September.
In this article: FLXN, ALXN, PTCT Also: JNJ, TSRO, ACRX, AERI
Read
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Article By: Arpita Dutt
Monday, July 17, 2017 11:35 AM EST
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read
Sanofi To Buy Flexion Therapeutics, Inc. For +$1 Billion In Cash
Article By: Lorimer Wilson
Thursday, March 23, 2017 6:04 PM EST
Sanofi is in talks to buy Flexion Therapeutics, Inc. a Boston-area biotech with its lead product now awaiting FDA approval, for more than $1 billion in cash, according to a source close to the deal.
In this article: SNY, FLXN Also: JNJ, PFE
Read

PARTNER HEADLINES

Latest Tweets for $FLXN

No tweets yet!

$FLXN

Wither Flexion?
Adam Reynolds 11/25/2019 12:13:44 AM

Sounds like it's time to short! $FLXN

Wither Flexion?
Harry Goldstein 11/24/2019 7:22:49 PM

So $FLXN is essentially a one trick pony? Didn't realize Zilretta was so critical to the companies existence. Do you know what percentage of its profits are tied to this one therapy?

1 to 2 of 2 comments